Ignite Creation Date:
2025-12-24 @ 5:01 PM
Ignite Modification Date:
2026-01-04 @ 7:05 AM
Study NCT ID:
NCT02955550
Status:
COMPLETED
Last Update Posted:
2020-07-22
First Post:
2016-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)
Sponsor:
Celularity Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-05
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-04
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-02
First Submit QC Date:
None
Study First Post Date:
2016-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-20
Last Update Post Date:
2020-07-22
Last Update Post Date Type:
ACTUAL